AngioDynamics Inc. has announced that its Annual Meeting of Shareholders will be held virtually on November 10, 2025. During the meeting, shareholders will vote on the election of two Class I directors for a term of three years, the ratification of the appointment of AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2026, and an advisory "Say-on-Pay" vote on the compensation of the company's named executive officers. Additional business may also be transacted as appropriate.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AngioDynamics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-042704), on September 25, 2025, and is solely responsible for the information contained therein.